Clinical Trials Browser

Phase 2 × OTHER_GOV × eltrombopag × Clear all

NCT05286164 2022-04-15

Eltrombopag Treatment in Patients With Prolonged BM Toxicity After CART

Phase 2 Unknown

Lymphoma, B-Cell